Skip to search formSkip to main contentSkip to account menu

Advair

National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationFluticasone propionatefluticasonesalmeterol
Seretide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
BACKGROUND Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta… 
2015
2015
Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair(®) in chronic obstructive pulmonary disease.
2015
2015
Profound hypertension with dexmedetomidine during insertion of deep brain stimulator
Abstract Dexmedetomidine is now frequently used in the anaesthetic management of patients undergoing deep brain stimulator… 
2014
2014
COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
Review
2010
Review
2010
PRS40 THE IMPACT OF THE FDA'S RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
Review
2010
Review
2010
PRS44 ANTIBIOTIC PRESCRIBING FOR ACUTE RESPIRATORY TRACT INFECTIONS IN ADULT PRIMARY CARE: IS GOOD INSURANCE BAD FOR ANTIBIOTIC PRESCRIBING?
Review
2010
Review
2010
PRS42 IMPACT OF THE UK PUBLIC SMOKING BAN ON THE PRESCRIBING OF SMOKING CESSATION THERAPY IN PRIMARY CARE^A THIN DATABASE STUDY
Review
2009
Review
2009
Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.
In December 2008, the FDA reviewed the risks and benefits of inhaled long-acting beta-agonists for the treatment of asthma in… 
2006
2006
Fluticasone propionate/salmeterol hydrofluoroalkane via metered‐dose inhaler with integrated dose counter: performance and patient satisfaction
Currently, patients have to keep track of doses to determine when to replace their metered‐dose inhalers (MDIs). This study… 
Review
2006
Review
2006
Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial.
CONTEXT Chronic obstructive pulmonary disease (COPD) is recognized as a major healthcare problem in the United States and around… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)